Rituximab in Childhood Lupus: Insights and Safety

Join Dr. Anna Wolska and Dr. Jordan Roberts, a pediatric rheumatologist, as they explore the use of Rituximab in treating childhood-onset systemic lupus erythematosus (SLE). They discuss key factors for healthcare providers when prescribing Rituximab to children and adolescents, especially for severe cases like lupus nephritis and CNS involvement. Dr. Roberts presents recent research on Rituximab’s safety, highlighting increased infection risks and the need for targeted prevention strategies. Tune in for expert insights on the latest advancements, challenges, and future directions in pediatric lupus treatment. Read the paper published in LSM -

You can listen to Rituximab in Childhood Lupus: Insights and Safety online on Radio and Podcast. Open the player on this page to stream the available audio.

Rituximab in Childhood Lupus: Insights and Safety is an episode from Lupus Science and Medicine podcast by BMJ Group.

This episode is 15:12 long.

This episode was published on Jan 6, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Lupus Science and Medicine podcast when more episodes are available from the podcast feed.